Carboplatin-Paclitaxel Adjuvant Chemotherapy in the Treatment of Locally Advanced Cervical Cancer
Status:
Recruiting
Trial end date:
2023-12-01
Target enrollment:
Participant gender:
Summary
This is a mutlicentric, open-label non-randomized, national, 1-stage phase II trial to assess
efficacy and safety of a weekly Carboplatin-Paclitaxel adjuvant chemotherapy after intensity
modulated extended-field chemoradiation in patient suffering from of locally advanced
cervical cancer with para-aortic positive nodes.